Neurovalens

Belfast, United Kingdom

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology

$6.8M raised

May 2026

Grant

Top Investors

British Business BankIQ CapitalWhiterock FinanceACF InvestorsFuture Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neurovalens raised?

Neurovalens has raised $6.8M in total funding. The most recent round was Grant. The last funding was announced in May 2026.

Who are Neurovalens's investors?

Neurovalens's investors include British Business Bank, IQ Capital, Whiterock Finance, ACF Investors, Future Fund.

Where is Neurovalens headquartered?

Neurovalens is headquartered in Belfast, United Kingdom.

What does Neurovalens do?

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology

What stage is Neurovalens at?

Neurovalens is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 26, 2026.

MLA

"Neurovalens — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/neurovalens. Accessed June 3, 2026.

APA

VCBacked. (2026). Neurovalens — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/neurovalens

Wikipedia (cite web)

{{cite web |title=Neurovalens — Funding & Investors |url=https://www.vcbacked.co/company/neurovalens |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 26, 2026.